| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7abd8b03c6272c46417f9d8292693614 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-2261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22064 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-22 |
| filingDate |
2000-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13bd02b10fad4ba667c185f3fd77974d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9de531da4a3a7e9c4ea9033f38c4bf9 |
| publicationDate |
2003-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6520957-B1 |
| titleOfInvention |
Treatment of in-stent restenosis using cytotoxic radiation |
| abstract |
Methods and systems are disclosed for treating in-stent restenosis using radiation having a wavelength sufficient to kill or promote cellular death (e.g., through programmed cell death), or otherwise remove smooth muscle cells which have proliferated, or which might otherwise proliferate, in the proximity of (i.e., within, around or adjacent to) a stent within a body lumen, causing (or potentially causing) at least partial blockage of the lumen. Devices are disclosed for providing such therapeutic radiation at the stent with or without concurrent mechanical (e.g. balloon dilation) angioplasty. Treatment methods are also disclosed which include irradiating smooth muscle cells in the region of the stenosis with non-ablative, cytotoxic radiation, such as UV radiation. A cytotoxic, photoactivatable chromophore may also be delivered to the treatment site prior to irradiation. The methods and systems can be used prophylactically or to treat in-stent restenosis after blockage has occurred without further damage to surrounding tissue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006167531-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006195165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006271024-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191937-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8109981-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007191938-A1 |
| priorityDate |
1997-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |